Can I have it? The drug in question is Semaglutide, a once-weekly injectable GLP-1 analogue currently used for diabetes management
Alternative options available on the NHS: For individuals with obesity who meet eligibility criteria, the NHS offers several evidence-based interventions: Tier 3 weight management services: Multidisciplinary programmes including dietary advice, physical activity support, behavioural interventions, and psychological support Bariatric surgery: Gastric bypass, sleeve gastrectomy, or adjustable gastric banding for those with BMI 40 kg/m (or 35 kg/m with obesity-related comorbidities such as type 2 diabetes or high blood pressure) who have tried other weight loss methods
In this study, we found that dietary supplementation with 58.80312.00 mg/kg TAs could reduce the expression of intestinal FXR and SMPD3
fiercepharma.com 5Drug Discovery Trends (November 2025)
In the foundational study by Raun et al
Athletic Performance Impairment Perhaps most striking: caffeine doesn't uniformly enhance performance
